Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.024 | 0.8 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |